ZA982371B - Humanized anti-human fas antibody - Google Patents

Humanized anti-human fas antibody

Info

Publication number
ZA982371B
ZA982371B ZA982371A ZA982371A ZA982371B ZA 982371 B ZA982371 B ZA 982371B ZA 982371 A ZA982371 A ZA 982371A ZA 982371 A ZA982371 A ZA 982371A ZA 982371 B ZA982371 B ZA 982371B
Authority
ZA
South Africa
Prior art keywords
humanized anti
fas antibody
human fas
human
antibody
Prior art date
Application number
ZA982371A
Other languages
English (en)
Inventor
Nobufusa Serizawa
Tohru Takahashi
Shin Yonehara
Hideyuki Haruyama
Kaori Nakahara
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of ZA982371B publication Critical patent/ZA982371B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA982371A 1997-03-21 1998-03-19 Humanized anti-human fas antibody ZA982371B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6793897 1997-03-21

Publications (1)

Publication Number Publication Date
ZA982371B true ZA982371B (en) 1998-09-28

Family

ID=13359383

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA982371A ZA982371B (en) 1997-03-21 1998-03-19 Humanized anti-human fas antibody

Country Status (15)

Country Link
EP (1) EP0866131A3 (cs)
KR (1) KR19980080514A (cs)
AR (1) AR012148A1 (cs)
AU (1) AU736287B2 (cs)
BR (1) BR9800937A (cs)
CA (1) CA2232828A1 (cs)
CZ (1) CZ85898A3 (cs)
HU (1) HUP9800613A3 (cs)
ID (1) ID20065A (cs)
IL (1) IL123756A0 (cs)
NO (1) NO981272L (cs)
NZ (1) NZ330004A (cs)
PL (1) PL325457A1 (cs)
TR (1) TR199800517A3 (cs)
ZA (1) ZA982371B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6972323B1 (en) 1997-04-01 2005-12-06 Sankyo Company, Limited Anti-Fas antibodies
EP1087993B1 (en) 1998-06-18 2008-04-02 Imed Ab Fas peptides and antibodies for modulating apoptosis
AU757961B2 (en) * 1998-09-30 2003-03-13 Sankyo Company Limited Anti-Fas antibodies
EP1143994B1 (en) * 1999-01-11 2003-07-02 Leadd B.V. Use of apoptosis inducing agents in the preparation of a medicament for the treatment of (auto)immune diseases
AU2004233486B2 (en) * 1999-01-11 2007-09-13 Leadd B.V. Use of apoptosis inducing agents in the treatment of (auto)immune diseases
MXPA01012206A (es) 1999-05-24 2002-06-21 Sankyo Co Composiciones farmaceuticas que contienen anticuerpo anti-fas.
WO2003072736A2 (en) * 2002-02-21 2003-09-04 Duke University Reagents and treatment methods for autoimmune diseases
US20060083738A1 (en) * 2002-05-17 2006-04-20 Fusion Antibodies Limited Treatment of cancer by the use of anti fas antibody
GB0306618D0 (en) * 2003-03-22 2003-04-30 Univ Newcastle Antibody
EP1999148B8 (en) 2006-03-06 2014-03-05 Medlmmune, LLC Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
US8030026B2 (en) * 2009-02-24 2011-10-04 Abbott Laboratories Antibodies to troponin I and methods of use thereof
CA3004830A1 (en) 2015-11-11 2017-05-18 Opi Vi- Ip Holdco Llc Composition and methods for anti-tnfr2 antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162181A (en) * 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
EP1400536A1 (en) * 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
WO1995010540A1 (en) * 1993-10-14 1995-04-20 Immunex Corporation Fas antagonists and uses thereof
CA2158822C (en) * 1994-09-27 2008-12-23 Kusuki Nishioka Therapeutic agent for rheumatic disease
AU724579B2 (en) * 1996-04-01 2000-09-28 Sankyo Company Limited Anti-Fas recombinant antibodies and DNA therefor

Also Published As

Publication number Publication date
NO981272L (no) 1998-09-22
EP0866131A2 (en) 1998-09-23
HUP9800613A2 (hu) 1999-02-01
KR19980080514A (ko) 1998-11-25
NZ330004A (en) 1998-10-28
IL123756A0 (en) 1998-10-30
CA2232828A1 (en) 1998-09-21
CZ85898A3 (cs) 1998-10-14
HUP9800613A3 (en) 2001-04-28
AU736287B2 (en) 2001-07-26
TR199800517A2 (xx) 1998-10-21
BR9800937A (pt) 2000-01-11
EP0866131A3 (en) 1999-12-15
TR199800517A3 (tr) 1998-10-21
AR012148A1 (es) 2000-09-27
HU9800613D0 (en) 1998-05-28
NO981272D0 (no) 1998-03-20
ID20065A (id) 1998-09-24
PL325457A1 (en) 1998-09-28
AU5937598A (en) 1998-10-15

Similar Documents

Publication Publication Date Title
HU9503638D0 (en) Anti-alpha-v-integrin monoclonal antibody
IL128406A0 (en) Monoclonal antibodies
EP1073464A4 (en) MONOCLONAL ANTIBODIES WITH REDUCED IMMUNIZABILITY
AU1462300A (en) Human pan-hcv human monoclonal antibodies
DK1516629T3 (da) Humaniseret anti-CD-11a antibodies
ZA949341B (en) Humanized antibodies and uses thereof
HUP0104604A3 (en) Human monoclonal antibodies to ctla-4
AU4618193A (en) Humanized antibodies
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
ZA982371B (en) Humanized anti-human fas antibody
EP0578515A3 (en) Humanized monoclonal antibodies.
GB9608626D0 (en) Hepatitis b monoclonal antibodies
AU7072998A (en) Immunoassays using anti-allotypic monoclonal antibodies
GB9718911D0 (en) Monoclonal antibodies
AU2596397A (en) Monoclonal antibody that detects apoptotic antigen
ZA951113B (en) Tumor assosiated monoclonal antibody 123av16
EP1106701A4 (en) MONOCLONAL ANTIBODY DIRECTED AGAINST DYNAMIC TRYPSIN
AP9801381A0 (en) Anti-human mp52 monoclonal antibody
GB9615027D0 (en) Monoclonal antibodies
GB9212074D0 (en) Monoclonal antibody
SG64332A1 (en) Monoclonal antibody
GB9806698D0 (en) Chimeric antibodies
IL125204A0 (en) Anti-bacterial monoclonal antibodies
IL127249A0 (en) Human monoclonal antibodies to the hepatitis b surface antigen